"Restriction order" and then upgrade the National Health and Care Commission issued new rules concerning all doctors.

Pharmaceutical Network July 24th, 2012, "antimicrobial clinical application management measures" officially implemented, then was called "the history of the most severe resistance order."
in the following years, the country issued a number of times, and continuously improve the use of antimicrobial drugs threshold and supervision.
this year, without exception, "limited resistance order" upgrade again! On July 23, the National Health and Care Commission issued a Notice on the Continuous Management of clinical applications of antimicrobial drugs (hereinafter referred to as the "Notice").
notice requires medical institutions to implement the main responsibility for the clinical application management of antimicrobial drugs, and put forward specific requirements, some of which are closely related to front-line doctors.
such doctors, no antimicrobial prescription "notice" stipulates that hospitals above the second level should strictly implement the "Clinical Application Management Measures for Antibacterial Drugs" requirements, and regularly conduct clinical application knowledge and standardized management of antimicrobial drugs for physicians and pharmacists training.
physicians may not grant the right to prescribe antimicrobial drugs without training and passing the examination of this institution.
hospitals may not grant the appropriate prescription authority solely on the basis of the title of physician.
compared with last year's National Health and Care Commission issued "on the continuous management of the clinical application of antimicrobial drugs notice", this year stressed that "physicians without the training and assessment of the institution qualified, may not grant the right to prescribe antimicrobial drugs."
in addition, the Notice suggests that in the future, the use of information-based means to achieve the granting of prescription authority, prescription, prescription audit, preventive drug use, specimen inspection and other key links of intelligent management.
it seems that in the future, the issue of antimicrobial prescription rights to adopt stricter regulation, we must be careful.
strengthen the "Notice" on the management of primary antimicrobial drugs, local health administrative departments at all levels should attach importance to the management of county hospitals and primary medical institutions, play the role of medical associations, counterpart support to promote support, guide the grass-roots standard use of antimicrobial drugs.
should do a good job in the supervision and management of antimicrobial-related monitoring, regularly carry out results analysis and notification, improve the application of antimicrobial drugs and management evaluation standards, improve the level of scientific management.
the primary physician commune here to remind everyone three points: First, the village health rooms, clinics and community health service stations using antibacterial drugs to carry out intravenous infusion activities, should be approved by the county-level health administrative departments.
second, can not cross-level use of antimicrobial drugs, the grass-roots can use antimicrobial drugs mainly to non-restricted use level and restricted use level.
details can be referred to: "restriction order upgrade, these drugs can not be used at the grass-roots (attached list)" Third, primary health care institutions can only choose essential drugs (including the provinces and municipalities supplementary varieties) of antimicrobial drug varieties.
reasonable control of carbon penicillin, the use of tetracycline should continue to take effective measures to strengthen carbon penicillin, tyga cyclin and other key antimicrobial drugs special file management, its use strength control at a reasonable level.
it is understood that the domestic varieties of carbon penicillin have been listed are amine perinan, merobinan, Pani Penan, Ertapinan, Biapenan, Doni Penan.
focus on preventive use, joint use and intravenous infusion, intrauterine injection, joint injection of antimicrobials.
to encourage qualified medical institutions to carry out monitoring of the concentration of therapeutic drugs for key antimicrobial drugs and guide clinical precision drug use.
antimicrobial drugs as the key medical institutions for medical advice audit and prescription review should strengthen the construction of pharmaceutical disciplines, improve the clinical pharmacists on the clinical application management of antimicrobial drugs participation and participation level.
play its active role in multidisciplinary consultation of infectious diseases, the development of guidelines for diagnosis and treatment of infectious diseases and clinical pathways.
should take antimicrobial drugs as the focus of medical advice review and prescription review, and improve the diagnosis and treatment program in a timely manner.
the establishment of infectious diseases departments in secondary and higher general hospitals in recent years, the state and provinces have introduced corresponding programs to reduce unreasonable intravenous infusions.
this year, the state again put forward new requirements: secondary and above general hospitals in accordance with the provisions of the establishment of infectious diseases, and by the end of 2020 to treat bacterial fungal infection as the main disease of the infection area or medical groups.
to treat the ability of major bacterial fungal infectious diseases and the clinical application management of antimicrobial drugs as an important part of the construction of infectious diseases.
this initiative can be said to be fundamental to solve the problem, by improving the level and quality of infectious diseasediagnosis to further promote the rational use of antimicrobial drugs, and even reduce the use.
since 2012, these eight years, "restriction order" has been upgraded, as a first-line clinician only to achieve "reasonable" two is fundamental.
attached: "Notice on the continuous management of clinical application of antimicrobial drugs" The original State Health and Health Commission Office on the continued management of the clinical application of antimicrobial drugs notice of the State Health Administration Medical Development (2020) No. 8 provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health and Health Committee: in order to further implement the "on strengthening the pharmaceutical affairs of medical institutions" The Opinions on Management and Promotion of Rational Drug Use and the National Action Plan for Curbing Bacterial Resistance (2016-2020) continue to raise the level of rational use of antimicrobial drugs, and medical institutions should continuously improve their understanding of the importance of the management of clinical application sandfighting drugs, identify the responsible departments and responsible persons, and effectively implement management responsibilities.
now put forward the following requirements for the continuous management of clinical application of antimicrobial drugs.
. And continuously improve the level of diagnosis and treatment of infectious diseases (i) strengthen the construction of infectious diseases.
to implement the relevant requirements for strengthening the construction of infectious diseases departments, general hospitals at or above the second level shall set up infectious diseases departments in accordance with the provisions, and set up infectious diseases or medical groups to treat bacterial fungal infections as the main diseases by the end of 2020.
to treat the ability of major bacterial fungal infectious diseases and the clinical application management of antimicrobial drugs as an important part of the construction of infectious diseases.
strengthen the training of medical personnel of the Infectious Diseases Section to enable them to fully and in-depth grasp the relevant laws, regulations and standards for the clinical use of antimicrobial drugs, and further improve their professional and technical skills.
(ii) improve the quality of medical care for infectious diseases.
medical institutions should take the return of infectious diseases and improve the quality of medical care as the goal, give full play to the infectious diseases department of the hospital's clinical application of antimicrobial drugs guidance.
promote the clinical application level of antimicrobial drugs in the whole hospital by formulating the norms and clinical paths of infectious diseases, carrying out consultations on difficult infectious diseases, etc.
should pay attention to the use of newly listed antimicrobial drugs, joint use of antimicrobial drugs and the emergence of antimicrobial drugs multi-drug cases of consultation.
, the implementation of the relevant requirements for pharmaceutical management (iii) optimize the supply of antimicrobial drugs catalog.
medical institutions should optimize the supply of antimicrobialdrugs in conjunction with the "1 plus X" drug use model, which is dominated by essential drugs ("1" is the national list of essential drugs and "X" is non-essential drugs).
in the formulation of the agency's antimicrobial drug supply catalogue and prescription set, in addition to the prescribed specifications to ensure the selection of similar drugs should be selected safe, effective, economic and evidence-based evidence-based varieties.
(iv) improve the level of pharmacy professional and technical services.
medical institutions should strengthen the construction of pharmaceutical disciplines and improve the participation and level of participation of clinical pharmacists in the management of clinical applications of antimicrobial drugs.
play its active role in multidisciplinary consultation of infectious diseases, the development of guidelines for diagnosis and treatment of infectious diseases and clinical pathways.
should take antimicrobial drugs as the focus of medical advice review and prescription review, and improve the diagnosis and treatment program in a timely manner.
(v) strengthen the management of key links.
should continue to take effective measures to strengthen carbon penicillin, tygrigin and other key antimicrobial drugs special file management, its use strength control at a reasonable level.
focus on preventive use, joint use and intravenous infusion, intrauterine injection, joint injection of antimicrobials.
to encourage qualified medical institutions to carry out monitoring of the concentration of therapeutic drugs for key antimicrobial drugs and guide clinical precision drug use.
, strengthen infection prevention and control (vi) to improve the control of sensing management.
all places should promote the overall deployment of infection prevention and control and clinical application management of antimicrobial drugs in medical institutions, and continue to increase investment in infection prevention and control work.
medical institutions shall strengthen the capacity-building of the sensing and control departments, highlight the functional orientation of business management and professional and technical services, and the personnel should master the knowledge of infectious diseases.
to implement the training requirements of the full staff, and antimicrobial clinical application management and other related knowledge into the training content.
(7) play the role of sensor control in the management of antimicrobial drugs.
medical institutions should participate in the clinical application management of antimicrobial drugs, as well as multidisciplinary consultation of infectious diseases.
to promote the implementation of standards to prevent the requirements, improve the health of medical personnel, strict implementation of disinfection and isolation and other relevant standards.
should strengthen the care of long-term bed-ridden patients and the control and control of patients with key drug-resistant bacteria infection, reduce the risk of in-hospital infection, reduce the preventive use of antimicrobial drugs.
, strengthen testing support, promote the precise use of antimicrobial drugs (viii) strengthen the construction of clinical testing laboratory.
all over the country should be combined with the prevention and control of the new crown pneumonia epidemic, and further strengthen the construction of clinical testing laboratory.
tertiary general hospital, infectious disease specialist hospital and a county-level hospital with strong comprehensive strength in the county area, it is necessary to have a new type of coronavirus nucleic acid detection capability; On the basis of nucleic acid testing, the
expands the scope of serological testing of common viral infections, improves the comprehensive ability of pathogen diagnosis, and does a good job of biosecurity management.
(nine) do a good job in specimen testing related work.
should increase the training of medical personnel to standardize the collection and transfer of microbial specimens.
clinical microbiology laboratory to strengthen the initial screening of specimens and the withdrawal of unqualified specimens, to ensure the quality of specimens, and through process modification to achieve timely reception and treatment of specimens.
to improve the rate of samples, especially blood, cerebrospinal fluid and other body fluids, and expand the range of bacterial culture conventional drug sensitivity tests involving drug varieties, timely identification of pathogens and culture results feedback to the clinic.
(10) to improve the level of microbiological testing.
microbiology laboratory to enhance the clinical awareness and ability of service, according to clinical needs, expand the testing project, do a good job of drug sensitivity results interpretation and specimen collection guidance.
at the same time, actively participate in the clinical application management of antimicrobial drugs, infectious diseases multidisciplinary consultation, to promote the rational use of antimicrobial drugs.
encourage competent laboratories to carry out molecular diagnostics of drug-resistant bacteria and actively explore rapid diagnostic techniques to improve the efficiency of diagnosis of infectious diseases.
Five, relying on the information construction, to help the scientific management of antimicrobial drugs (11) continue to strengthen the information construction.
medical institutions that have established information systems should embed the requirements related to antimicrobial drug management in the information system, and realize the intelligent management of key links such as the granting of prescription authority, prescription, prescription audit, preventive drug use, and sample delivery inspection by means of information.
to explore the clinical path of infectious diseases, the norms of diagnosis and treatment and the guidelines for clinical application of antimicrobial drugs, and so on, to further promote the scientific and normative application of antimicrobial drugs.
strengthen the construction of laboratory information system sourcing medical institutions, strengthen the report of bacterial fungal drug sensitivity test results and improve the quality of drug resistance monitoring data.
(12) to improve the level of monitoring and analysis.
encourage medical institutions above the second level to join the provincial or national clinical application monitoring network for antimicrobial drugs, the bacterial resistance monitoring network and the fungal disease monitoring network, and submit relevant data in accordance with the provisions.
uses information-based means to dynamically monitor the use of antimicrobial drugs, regularly carry out the basic situation of drug use and bacterial fungal resistance to investigate and analyze, in order to provide a scientific basis for timely intervention.
, strengthen training assessment, and comprehensively promote the management of antimicrobial drugs (13) to strengthen the right to prescribe training assessment.
secondary hospitals above the level of the strict implementation of the "antimicrobial drug clinical application management measures" requirements, doctors and pharmacists regularly to the clinical application of antimicrobial drugs knowledge and standardized management training.
physicians may not grant the right to prescribe antimicrobial drugs without training and passing the examination of this institution.
hospitals may not grant the appropriate prescription authority solely on the basis of the title of physician.
the administrative departments of health and health should further standardize the granting and management of the prescription rights of antimicrobial drugs in conjunction with the assessment of rational drug use in medical institutions, and supervise the implementation of the work.
(14) strengthen the supervision and management of guidance inspection.
local health and health administrative departments at all levels should attach importance to the management of county hospitals and primary medical institutions, play the role of medical associations, counterpart support to support the role of support, guide the basic level of standard use of antimicrobial drugs.
strengthen the construction of related professional quality control centers, such as pharmaceutical affairs and hospital sense, relying on professional organizations to carry out training, guidance and inspection.
should do a good job in the supervision and management of antimicrobial-related monitoring, regularly carry out results analysis and notification, improve the application of antimicrobial drugs and management evaluation standards, improve the level of scientific management.
, 20 July 2020 (Form of disclosure: active disclosure)